全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Taurolock Effectively Reduces Tunneled Dialysis Catheter-Related Infection and Catheter Exchange Rates among Hemodialysis Patients

DOI: 10.4236/ojneph.2016.62007, PP. 55-60

Keywords: Catheter, Hemodialysis, Infection, Prevention, Lock

Full-Text   Cite this paper   Add to My Lib

Abstract:

Aims: Catheter-related infection, which is one of the major side effects of the use of dialysis catheters, leads to increases in hospitalization, morbidity and mortality. Antibiotic lock is an option for reducing the incidence of these infections, but there are concerns regarding antibiotic resistance. A prior study demonstrated that Taurolock (a taurolidine lock) may reduce the rate of catheter-related infection. Methods and Material: This investigation was a prospective before-and-after study. During period one, patients continued to use a heparin lock (5000 units/ml) for 6 months. During period two, they were shifted to Taurolock (a solution of 1.35% taurolidine, 4% citrate, and 500 units/ml of heparin) for 6 months. The primary outcome was the incidence of tunneled catheter-related infection and/or catheter exchange, and the secondary outcomes were the effects of Taurolock on catheter flow rate, dialysis adequacy, and catheter malfunction rate. Results: A total of 49 patients were included in this study. During period one, the primary outcome occurred 17 times, with an incidence rate of 86.8 per 100 patient-years; during period two, the primary outcome occurred 7 times, with an incidence rate of 32.6 per 100 patient-years (incidence rate ratio: 2.65, 95% confidence interval (CI): 1.05 - 7.6, P = 0.023). There was no significant difference between the two periods with respect to mean catheter blood flow rate (P = 0.29). During period one, thrombolytic therapy (TPA) lock was indicated on 19 occasions, with an incidence rate of 97 per 100 patient-years; during period two, TPA lock was indicated on 53 occasions, with an incidence rate of 247.5 per 100 patient-years (incidence rate ratio: 0.3, 95% CI: 0.21 - 0.67, P = 0.0003). Conclusions: We demonstrated that Taurolock usage is safe and effective for the prevention of dialysis catheter-related infection and/or catheter exchange.

References

[1]  Andrew, S. and Coresh, J. (2002) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. American Journal of Kidney Diseases, 39, S1-S266.
[2]  Levey, A.S., Eckardt, K.U., Tsukamoto, Y., et al. (2005) Definition and Classification of Chronic Kidney Disease: A Position Statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International, 67, 2089-2100.
http://dx.doi.org/10.1111/j.1523-1755.2005.00365.x
[3]  Gilmore, J. (2006) K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations 2006 Updates. Nephrology Nursing Journal, 33, 487-488.
[4]  Lee, T., Barker, J. and Allon, M. (2005) Tunneled Catheters in Hemodialysis Patients: Reasons and Subsequent Outcomes. American Journal of Kidney Diseases, 46, 501-508.
http://dx.doi.org/10.1053/j.ajkd.2005.05.024
[5]  Danese, M.D., Griffiths, R.I. and Dylan, M. (2006) Mortality Differences among Organisms Causing Septicemia in Hemodialysis Patients. Hemodialysis International, 10, 56-62.
http://dx.doi.org/10.1111/j.1542-4758.2006.01175.x
[6]  Nissenson, A.R., Dylan, M.L. and Griffiths, R.I. (2005) .Clinical and Economic Outcomes of Staphylococcus aureus Septicemia in ESRD Patients Receiving Hemo-dialysis. American Journal of Kidney Diseases, 46, 301-308.
http://dx.doi.org/10.1053/j.ajkd.2005.04.019
[7]  Abbas, S.A., Haloob, I.A. and Taylor, S.L. (2009) Effect of Antimicrobial Locks for Tunneled Hemodialysis Catheters on Bloodstream Infection and Bacterial Resistance: A Quality Improvement Report. American Journal of Kidney Diseases, 53, 492-502.
http://dx.doi.org/10.1053/j.ajkd.2008.09.019
[8]  Bleyer, A.J. (2007) Use of Antimicrobial Catheter Lock Solutions to Prevent Catheter-Related Bacteremia. Clinical Journal of the American Society of Nephrology, 2, 1073-1078.
http://dx.doi.org/10.2215/CJN.00290107
[9]  Yahav, D., Rozen-Zvi, B. and Gafter-Gvili, A. (2008) Antimicrobial Lock Solutions for the Prevention of Infections Associated with Intravascular Catheters in Patients Undergoing Hemo-dialysis: Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Clinical Infectious Diseases, 4, 83-93.
http://dx.doi.org/10.1086/588667
[10]  Shah, C.B., Mittelman, M.W. and Costerton, J.W. (2002) Antimicrobial Activity of a Novel Catheter Lock Solution. Antimicrobial Agents and Chemotherapy, 46, 1674-1679.
http://dx.doi.org/10.1128/AAC.46.6.1674-1679.2002
[11]  Allon, M. (2008) Prophylaxis against Dialysis Catheter-Related Bacteremia: A Glimmer of Hope. American Journal of Kidney Diseases, 51, 165-168.
http://dx.doi.org/10.1053/j.ajkd.2007.12.003
[12]  Ridão Curty, N.F., da Silva Martins, L.F. and Sanches Ito, C.A. (2014) Morbimortality Study of Infection in Patients Undergoing Different Types of Dialysis in a Renal Replacement Therapy Center. Brazilian Journal of Infectious Diseases, 18, 281-286. http://dx.doi.org/10.1016/j.bjid.2013.08.007
[13]  Ravani, P., Gillespie, B.W. and Quinn, R.R. (2013) Temporal Risk Profile for Infectious and Noninfectious Complications of Hemodialysis Access. Journal of the American Society of Nephrology, 24, 1668-1677.
http://dx.doi.org/10.1681/ASN.2012121234
[14]  Betjes, M.G. and van Agteren, M. (2004) Prevention of Dialysis Catheter-Related Sepsis with Acitrate-Taurolidine Containing Lock Solution. Nephrology Dialysis Transplantation, 19, 1546-1551.
http://dx.doi.org/10.1093/ndt/gfh014
[15]  Murray, E.C., Deighan, C. and Geddes, C. (2014) Taurolidine-Citrate-Heparin Catheter Lock Solution Reduces Staphylococcal Bacteraemia Rates in Haemodialysis Patients. QJM, 107, 995-1000.
http://dx.doi.org/10.1093/qjmed/hcu128
[16]  Taylor, C., Cahill, J. and Gerrish, M, (2008) A New Hemodialysis Catheter-Locking Agent Reduces Infections in Hemodialysis Patients. Journal of Renal Care, 34, 116-120.
http://dx.doi.org/10.1111/j.1755-6686.2008.00027.x
[17]  Solomon, L.R., Cheesbrough, J.S. and Ebah, L. (2010) A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated with Hemodialysis. American Journal of Kidney Diseases, 55, 1060-1068.
http://dx.doi.org/10.1053/j.ajkd.2009.11.025
[18]  Liu, H., Liu, H. and Deng, J. (2014) Preventing Catheter-Related Bacteremia with Taurolidine-Citrate Catheter Locks: A Systematic Review and Meta-Analysis. Blood Purification, 37, 179-187.
http://dx.doi.org/10.1159/000360271
[19]  Fontseré, N., Cardozo, C. and Donate, J. (2014) Tunneled Catheters with Taurolidine-Citrate-Heparin Lock Solution Significantly Improve the Inflammatory Profile of Hemodialysis Patients. Antimicrobial Agents and Chemotherapy. Antimicrobial Agents and Chemotherapy, 58, 4180-4184.
http://dx.doi.org/10.1128/AAC.02421-14
[20]  Allon, M. (2003) Prophylaxis against Dialysis Catheter-Related Bacteremia with a Novel Antimicrobial Lock Solution. Clinical Infectious Diseases, 36, 1539-1544.
http://dx.doi.org/10.1086/375234
[21]  Buturovic, J., Ponikva, R. and Kandus, A. (1998) Filling Hemodialysis Catheters in the Interdialytic Period. Heparin versus Citrate versus Polygeline: A Prospective Randomised Study. Artificial Organs, 22, 945-947.
http://dx.doi.org/10.1046/j.1525-1594.1998.06268.x

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133